comprehensive -WSS

comprehensive

author：focus 2025-09-06 02:04:17 - browse：5225

Eli Lilly said Friday it will acquire Versanis Bio, a private company developing an obesity drug that specifically targets fat mass, as the race among pharmaceutical companies to offer weight loss medications intensifies.

The deal indicates Lilly is aiming to diversify its growing portfolio of weight loss therapies, as Versanis’ drug employs an entirely different mechanism than the existing obesity drugs that Lilly is studying. The pharma giant didn’t say how much it would pay Versanis upfront, but said that if the drug meets certain milestones, the total payment could reach $1.9 billion.

Lilly, along with other pharma companies like Novo Nordisk, has been developing products in the class of GLP-1 drugs, which mimic the glucagon-like peptide 1 hormone that helps people feel full. These drugs – including Novo’s Ozempic and Wegovy, and Lilly’s Mounjaro – have exploded in popularity because they lead to significant weight loss.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： How CO2 helps viruses stay alive longer in the air

WSS

Stopping antidepressants leads to symptoms for 1 in 6 patients

Biden's Plan B on student loan forgiveness relies on Higher Education Act: What to know

Dramatic video released of Russian fighter jets 'harassing' US drones over Syria

China dismisses criticism of top diplomat's comments appearing to push for race

STAT wants to know your pick for a great summer read or listen

Pentagon will tighten controls on classified information after Discord leak

entertainment

comprehensive

explore

Psychedelics group wrestles with new pharma identity

3 protesters arrested at Wimbledon after interrupting matches by throwing confetti on court

Hollywood unions extend contract negotiations for actors

Former New York Mayor de Blasio and wife announce separation, but not divorce

At least 13 dead in Texas as scorching temps continue

Structure Therapeutics oral GLP

How to save PrEP access — and even expand it

Anthony Fauci pushes back on GOP claims during Covid hearing

Heart attack and stroke risk calculators need revising

Condition critical? Britain's beloved but battered National Health Service turns 75

entertainment

2 million sign

Adele warns fans about throwing things at performers onstage

Biden's Plan B on student loan forgiveness relies on Higher Education Act: What to know

Biden's Plan B on student loan forgiveness relies on Higher Education Act: What to know

City of Memphis, police chief oppose effort to delay lawsuit in Tyre Nichols case

'Insanity': 4th of July mass shootings across US kill 13, injure more than 80

focus

leisure time

leisure time

knowledge